Amgen Inc. (NASDAQ:AMGN) shares are trading close to its 52-week high on Wednesday after the company reported better-than-expected third-quarter financial results and raised its fiscal 2026 guidance.
79. 071 billion.
Product sales grew 8%, driven by volume growth; 17 products delivered at least double-digit sales growth and are annualizing at more than $1 billion based on third-quarter sales. 02.
936 billion. ” Post the quarter, analyst Luca Issi raised the price forecast from $430 to $470, with an Outperform rating.
Other analyst updates: Cantor Fitzgerald maintains the Neutral rating and raises the price forecast from $440 to $465. Wells Fargo keeps an Equal-Weight rating, raising the price forecast from $430 to $460.
Truist Securities maintains Amgen with a Hold and raises the price forecast from $380 to $398. 77 Wednesday.
64, according to Benzinga Pro data. Image via Shutterstock/ Melnikov Dmitriy Read Also: Wayfair CEO Says Best Growth Since Pandemic Is Just the Beginning AMD Is Growing Twice as Fast as Intel.
